Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001544227-20-000048
Filing Date
2020-11-10
Accepted
2020-11-10 07:49:00
Documents
4
Effectiveness Date
2020-11-10

Document Format Files

Seq Description Document Type Size
1 S-8 mlnd-202011xsx8.htm S-8 109292
2 EX-5.1 mlnd-202011xsx8exhibit51.htm EX-5.1 10977
3 EX-23.1 mlnd-202011xsx8exhibit231.htm EX-23.1 2508
4 image_21a.jpg GRAPHIC 8359
  Complete submission text file 0001544227-20-000048.txt   135488
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-249993 | Film No.: 201299658
SIC: 2834 Pharmaceutical Preparations